Result of AGM
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your COIL notes
Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth immunology and oncology markets, is pleased to announce that at the Company's Annual General Meeting ("AGM") held earlier today, all resolutions proposed were duly passed.
The resolutions were put to shareholders via a poll, the results of which were as follows:
| Resolution | Poll Results | Total Votes Withheld* | |||
|---|---|---|---|---|---|
| For | Against | Total Votes Cast | |||
| 1 | Shares | 15,989,492 | 205,120 | 16,194,612 | 289,738 |
| % | 98.73% | 1.27% | |||
| 2 | Shares | 15,758,683 | 432,163 | 16,190,846 | 293,504 |
| % | 97.33% | 2.67% | |||
| 3 | Shares | 15,668,163 | 522,683 | 16,190,846 | 293,504 |
| % | 96.77% | 3.23% | |||
| 4 | Shares | 15,842,448 | 352,163 | 16,194,611 | 289,739 |
| % | 97.83% | 2.17% | |||
| 5 | Shares | 15,842,449 | 352,163 | 16,194,612 | 289,738 |
| % | 97.83% | 2.17% | |||
| 6 | Shares | 15,989,492 | 205,120 | 16,194,612 | 289,738 |
| % | 98.73% | 1.27% | |||
| 7 | Shares | 15,989,492 | 205,120 | 16,194,612 | 289,738 |
| % | 98.73% | 1.27% | |||
| 8 | Shares | 15,671,929 | 522,683 | 16,194,612 | 289,738 |
| % | 96.77% | 3.23% | |||
| 9 | Shares | 15,636,863 | 557,749 | 16,194,612 | 289,738 |
| % | 96.56% | 3.44% |
* Votes withheld are not counted in the calculation of the proportion of votes for and against a resolution.
The total number of ordinary shares in issue on 24 June 2025, the deadline for casting votes by proxy in advance of the AGM, was 157,444,030 shares. 10.3% of voting capital was instructed in respect of the resolutions put to the AGM.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.